Suprasellar Hemangioblastoma on 68 Ga-DOTATATE PET/CT. Filizoglu, N. & Ozguven, S. Clinical Nuclear Medicine, 47(11):e700–e701, November, 2022.
doi  abstract   bibtex   
Von Hippel-Lindau (VHL) disease is an autosomal dominant hereditary cancer syndrome that is characterized by the presence of various malignant and benign tumors, including retinal and central nervous system hemangioblastomas. Hemangioblastomas are highly vascular tumors that can occur sporadically or within VHL disease. Herein, we present 68 Ga-DOTATATE PET/CT findings of a unique case of suprasellar hemangioblastoma in a 52-year-old man with VHL disease.
@article{filizoglu_suprasellar_2022,
	title = {Suprasellar {Hemangioblastoma} on 68 {Ga}-{DOTATATE} {PET}/{CT}},
	volume = {47},
	issn = {1536-0229},
	doi = {10.1097/RLU.0000000000004309},
	abstract = {Von Hippel-Lindau (VHL) disease is an autosomal dominant hereditary cancer syndrome that is characterized by the presence of various malignant and benign tumors, including retinal and central nervous system hemangioblastomas. Hemangioblastomas are highly vascular tumors that can occur sporadically or within VHL disease. Herein, we present 68 Ga-DOTATATE PET/CT findings of a unique case of suprasellar hemangioblastoma in a 52-year-old man with VHL disease.},
	language = {eng},
	number = {11},
	journal = {Clinical Nuclear Medicine},
	author = {Filizoglu, Nuh and Ozguven, Salih},
	month = nov,
	year = {2022},
	pmid = {35695763},
	keywords = {Case Study},
	pages = {e700--e701},
}

Downloads: 0